Drug Shortage Report for BRIVLERA

Last updated on 2018-05-05 History
Report ID 45634
Drug Identification Number 02452979
Brand name BRIVLERA
Common or Proper name BRIVARACETAM
Company Name UCB CANADA INC
Market Status MARKETED
Active Ingredient(s) BRIVARACETAM
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 60 TABLETS
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-04-13
Estimated end date 2018-04-30
Actual end date 2018-05-04
Shortage status Resolved
Updated date 2018-05-05
Company comments ALL OTHER BRIVARACETAM STRENGTHS ARE AVAILABLE (10MG, 25MG, 50MG AND 75MG)
Health Canada comments
Tier 3 Status No
Contact Address 2201 BRISTOL CIRCLE
OAKVILLE, ONTARIO
CANADA L6H 0J8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-04-13 English Compare
v2 2018-04-13 French Compare
v3 2018-04-14 English Compare
v4 2018-05-04 English Compare
v5 2018-05-04 French Compare
v6 2018-05-05 English Compare

Showing 1 to 6 of 6